Literature DB >> 20716277

Inflammation precedes the development of human malignant mesotheliomas in a SCID mouse xenograft model.

Jedd M Hillegass1, Arti Shukla, Sherrill A Lathrop, Maximilian B MacPherson, Stacie L Beuschel, Kelly J Butnor, Joseph R Testa, Harvey I Pass, Michele Carbone, Chad Steele, Brooke T Mossman.   

Abstract

Asbestos fibers cause chronic inflammation that may be critical to the development of malignant mesothelioma (MM). Two human MM cell lines (Hmeso, PPM Mill) were used in a SCID mouse xenograft model to assess time-dependent patterns of inflammation and tumor formation. After intraperitoneal (IP) injection of MM cells, mice were euthanized at 7, 14, and 30 days, and peritoneal lavage fluid (PLF) was examined for immune cell profiles and human and mouse cytokines. Increases in human MM-derived IL-6, IL-8, bFGF, and VEGF were observed in mice at 7 days postinjection of either MM line, and a striking neutrophilia was observed at all time points. Free-floating tumor spheroids developed in mice at 14 days, and both spheroids and adherent MM tumor masses occurred in all mice at 30 days. Results suggest that inflammation and cytokine production precede and may be critical to the development of MMs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20716277      PMCID: PMC2936775          DOI: 10.1111/j.1749-6632.2010.05554.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  37 in total

Review 1.  Asbestos-related diseases.

Authors:  B T Mossman; J B Gee
Journal:  N Engl J Med       Date:  1989-06-29       Impact factor: 91.245

2.  Comparison of production of transforming growth factor-beta and platelet-derived growth factor by normal human mesothelial cells and mesothelioma cell lines.

Authors:  B I Gerwin; J F Lechner; R R Reddel; A B Roberts; K C Robbins; E W Gabrielson; C C Harris
Journal:  Cancer Res       Date:  1987-12-01       Impact factor: 12.701

Review 3.  The immunopathology of chemotactic cytokines: the role of interleukin-8 and monocyte chemoattractant protein-1.

Authors:  R M Strieter; A E Koch; V B Antony; R B Fick; T J Standiford; S L Kunkel
Journal:  J Lab Clin Med       Date:  1994-02

4.  Basic fibroblast growth factor in mesothelioma pleural effusions: correlation with patient survival and angiogenesis.

Authors:  L Strizzi; G Vianale; A Catalano; R Muraro; L Mutti; A Procopio
Journal:  Int J Oncol       Date:  2001-05       Impact factor: 5.650

Review 5.  Multiple roles of oxidants in the pathogenesis of asbestos-induced diseases.

Authors:  Arti Shukla; Mary Gulumian; Tom K Hei; David Kamp; Qamar Rahman; Brooke T Mossman
Journal:  Free Radic Biol Med       Date:  2003-05-01       Impact factor: 7.376

6.  Asbestos: scientific developments and implications for public policy.

Authors:  B T Mossman; J Bignon; M Corn; A Seaton; J B Gee
Journal:  Science       Date:  1990-01-19       Impact factor: 47.728

7.  Characterization of a human malignant mesothelioma cell line (H-MESO-1): a biphasic solid and ascitic tumor model.

Authors:  F R Reale; T W Griffin; J M Compton; S Graham; P L Townes; A Bogden
Journal:  Cancer Res       Date:  1987-06-15       Impact factor: 12.701

8.  Human peritoneal mesothelial cells produce many cytokines (granulocyte colony-stimulating factor [CSF], granulocyte-monocyte-CSF, macrophage-CSF, interleukin-1 [IL-1], and IL-6) and are activated and stimulated to grow by IL-1.

Authors:  L Lanfrancone; D Boraschi; P Ghiara; B Falini; F Grignani; G Peri; A Mantovani; P G Pelicci
Journal:  Blood       Date:  1992-12-01       Impact factor: 22.113

9.  Hematopoietic growth factors secreted by seven human pleural mesothelioma cell lines: interleukin-6 production as a common feature.

Authors:  D Schmitter; B Lauber; B Fagg; R A Stahel
Journal:  Int J Cancer       Date:  1992-05-08       Impact factor: 7.396

10.  Expression of c-sis (PDGF B-chain) and PDGF A-chain genes in ten human malignant mesothelioma cell lines derived from primary and metastatic tumors.

Authors:  M A Versnel; A Hagemeijer; M J Bouts; T H van der Kwast; H C Hoogsteden
Journal:  Oncogene       Date:  1988-06       Impact factor: 9.867

View more
  36 in total

1.  A multifunctional mesothelin antibody-tagged microparticle targets human mesotheliomas.

Authors:  Sherrill L Macura; Jedd M Hillegass; Jeremy L Steinbacher; Maximilian B MacPherson; Arti Shukla; Stacie L Beuschel; Timothy N Perkins; Kelly J Butnor; Melissa J Lathrop; Mutlay Sayan; Khan Hekmatyar; Douglas J Taatjes; Risto A Kauppinen; Christopher C Landry; Brooke T Mossman
Journal:  J Histochem Cytochem       Date:  2012-06-21       Impact factor: 2.479

2.  HSP90 inhibition alters the chemotherapy-driven rearrangement of the oncogenic secretome.

Authors:  Simona di Martino; Carla Azzurra Amoreo; Barbara Nuvoli; Rossella Galati; Sabrina Strano; Francesco Facciolo; Gabriele Alessandrini; Harvey I Pass; Gennaro Ciliberto; Giovanni Blandino; Ruggero De Maria; Mario Cioce
Journal:  Oncogene       Date:  2018-01-09       Impact factor: 9.867

3.  Molecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma.

Authors:  Michele Carbone; Haining Yang
Journal:  Clin Cancer Res       Date:  2011-11-07       Impact factor: 12.531

Review 4.  Mesothelioma: recent highlights.

Authors:  Michele Carbone; Haining Yang
Journal:  Ann Transl Med       Date:  2017-06

Review 5.  The Cappadocia mesothelioma epidemic: its influence in Turkey and abroad.

Authors:  Salih A Emri
Journal:  Ann Transl Med       Date:  2017-06

Review 6.  Bioanalytical techniques for detecting biomarkers of response to human asbestos exposure.

Authors:  Clementina Mesaros; Andrew J Worth; Nathaniel W Snyder; Melpo Christofidou-Solomidou; Anil Vachani; Steven M Albelda; Ian A Blair
Journal:  Bioanalysis       Date:  2015       Impact factor: 2.681

7.  Differential Susceptibility of Human Pleural and Peritoneal Mesothelial Cells to Asbestos Exposure.

Authors:  Julie Dragon; Joyce Thompson; Maximilian MacPherson; Arti Shukla
Journal:  J Cell Biochem       Date:  2015-08       Impact factor: 4.429

8.  Curcumin: a double hit on malignant mesothelioma.

Authors:  Jill M Miller; Joyce K Thompson; Maximilian B MacPherson; Stacie L Beuschel; Catherine M Westbom; Mutlay Sayan; Arti Shukla
Journal:  Cancer Prev Res (Phila)       Date:  2014-01-15

9.  Receptor role of the annexin A2 in the mesothelial endocytosis of crocidolite fibers.

Authors:  Kyoko Yamashita; Hirotaka Nagai; Shinya Toyokuni
Journal:  Lab Invest       Date:  2015-04-27       Impact factor: 5.662

10.  Extracellular signal-regulated kinase 5: a potential therapeutic target for malignant mesotheliomas.

Authors:  Arti Shukla; Jill M Miller; Christopher Cason; Mutlay Sayan; Maximilian B MacPherson; Stacie L Beuschel; Jedd Hillegass; Pamela M Vacek; Harvey I Pass; Brooke T Mossman
Journal:  Clin Cancer Res       Date:  2013-02-27       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.